Roche and Affimed in US$5bn cancer deal

09:30 EDT 16 May 2019 | European Biotechnology News

Original Article: Roche and Affimed in US$5bn cancer deal

More From BioPortfolio on "Roche and Affimed in US$5bn cancer deal"